We have identified the existence of mitochondrial uncoupling protein 2 (UCP2) in homeostatic circuits of healthy rodents and non-human primates. We also showed that ectopic expression of this uncoupling protein is induced in different models of neurodegeneration, including models of Parkinson's disease, hypoxia, epilepsy or trauma-induced brain injury. The expression of UCP2 in these experiments was associated with subpopulations of neurons and microglial cells at the site of the degenerative processes and predicted cells with the longest survival after the initial insult. In our preliminary studies, UCP2 overexpressing animals had diminished levels of free radical production in the brain and responded to transection of the entorhinal pathway with suppressed caspase 3 activation. We hypothesize that the induction of UCP2 in neurons and glial cells during pathological neurodegeneration is an attempt to protect and rescue injured neurons.
Three Specific Aims are proposed to test this hypothesis:
Specific Aim 1 To determine the role of the UCP2 gene product in intracellular calcium homeostasis and protection of cells in vitro by studying PC12 cells and primary cultures of retinal ganglion cells with and without UCP2 transfection and primary cultures of retinal ganglion cells taken from UCP2 transgenic, UCP2 knockout and wild type mice. The effects of oxygen and glucose deprivation and glutamate agonists will be assessed on cell death patterns and intracellular calcium metabolism in these cultures.
Specific Aim 2 To determine the pattern of neurodegeneration, mitochondrial uncoupling activity, cytokine and ATP production in the brains of UCP2 knockout mice, UCP2 overexpressing transgenic mice and wild type mice undergoing hypoxia-, seizure- or 1-methyl-4-phenyl- 1,2,5,6 tetrahydropyridine (MPTP)-induced neurodegeneration.
Specific Aim 3 To assess the effects on phenotype development of superoxide dismutase 2 knockout animals that are crossbred with either UCP2 knockout or UCP2 overexpressing mice. In these experiments, we will follow the phenotypic alterations by assessing neuronal loss, level of mitochondrial uncoupling activity, cytokine, free radical and ATP production and intracellular calcium levels using morphological, biochemical and molecular biological approaches. The results of the proposed studies will shed light on a novel mitochondrial mechanism that plays critical roles in the suppression of neurodegeneration regardless of the initial cause of disease. This will furnish one common target for the development of drugs against a variety of neurodegenerative pathologies, including those associated with hypoxia, epilepsy, Parkinson's, Alzheimer's and Huntington's Disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS041725-03
Application #
6685292
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Oliver, Eugene J
Project Start
2001-12-15
Project End
2006-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
3
Fiscal Year
2004
Total Cost
$388,313
Indirect Cost
Name
Yale University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Barnstable, Colin J; Reddy, Rajini; Li, Hong et al. (2016) Mitochondrial Uncoupling Protein 2 (UCP2) Regulates Retinal Ganglion Cell Number and Survival. J Mol Neurosci 58:461-9
Deierborg, Tomas; Deierborg Olsson, Tomas; Wieloch, Tadeusz et al. (2008) Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J Cereb Blood Flow Metab 28:1186-95
Rao, Yan; Liu, Zhong-Wu; Borok, Erzsebet et al. (2007) Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. J Clin Invest 117:4022-33
Rivera, A; Agnati, L F; Horvath, T L et al. (2006) Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: relevance for volume transmission. Neuroscience 137:1447-61
Andrews, Zane B; Rivera, Alicia; Elsworth, John D et al. (2006) Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function. Eur J Neurosci 24:32-6
Diano, Sabrina; Farr, Susan A; Benoit, Stephen C et al. (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9:381-8
Abizaid, Alfonso; Liu, Zhong-Wu; Andrews, Zane B et al. (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116:3229-39
Fuxe, K; Rivera, A; Jacobsen, K X et al. (2005) Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2. J Neural Transm 112:65-76
Andrews, Zane B; Horvath, Balazs; Barnstable, Colin J et al. (2005) Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J Neurosci 25:184-91
Horvath, Tamas L; Diano, Sabrina; Leranth, Csaba et al. (2003) Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology 144:2757-60

Showing the most recent 10 out of 16 publications